What is the role of GCSF in the treatment of Hodgkin lymphoma (Hodgkin disease)?

Updated: Sep 12, 2018
  • Author: Bradley W Lash, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print
Answer

There is some suggestion in the literature that granulocyte colony-stimulating factor (G-CSF) may increase rates of bleomycin lung injury, but this has not been confirmed. [77] In fact, the largest series in patients with germ-cell tumors did not show an increased risk of bleomycin lung injury with G-CSF use. [78]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!